ProShares UltraShort NASDAQ Biotechnology
4 hedge funds and large institutions have $464K invested in ProShares UltraShort NASDAQ Biotechnology in 2025 Q1 according to their latest regulatory filings, with funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
4
Holders Change
-2
Holders Change %
-33.33%
% of All Funds
0.05%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
2
Reduced
1
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$109K |
| 2 |
Morgan Stanley
New York
|
+$19 |
Top Sellers
| 1 |
Jane Street
New York
|
-$704K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
-$27K |
| 3 |
Citigroup
New York
|
-$1.55K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $390K | +$109K | +5,822 | +39% |
|
|
TRCT
2
Tower Research Capital (TRC)
New York
| $72.2K | -$27K | -1,449 | -27% |
|
|
3
Morgan Stanley
New York
| $1.42K | +$19 | +1 | +1% |
|
4
UBS Group
Zurich,
Switzerland
| $19 | – | – | – |
|
|
5
Jane Street
New York
| – | -$704K | -38,696 | Closed |
|
|
6
Citigroup
New York
| – | -$1.55K | -85 | Closed |
|